Thomas John Charles

Insider profile

Thomas John Charles's trades of Krystal Biotech Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-26 2026-06-25 PlS Planned sale
21,658 +5.1%
218.09
US$3,723,255
21,658 +5.1% 218.09 US$3,723,255
2026-06-25 2026-06-25 PrS Proposed sale
13,695
50.85
US$4,271,128
13,695 50.85 US$4,271,128
2026-05-27 2026-05-26 PlS Planned sale
40,553 -5.5%
259.07
US$4,181,500
40,553 -5.5% 259.07 US$4,181,500
2026-05-26 2026-05-26 PrS Proposed sale
642
302.03
US$193,903
642 302.03 US$193,903